RIC-3 differentially modulates α4β2 and α7 nicotinic receptor assembly, expression, and nicotine-induced receptor upregulation

BMC Neuroscience

Volumn 14, Issue , 2013, Pages

  Dau, Alejandro ^a   Komal, Pragya ^a   Truong, Mimi ^a   Morris, Geoff ^a   Evans, Gareth ^a   Nashmi, Raad ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

Author keywords

FRET; Ligand gated ion channels; Nicotine; Nicotinic acetylcholine receptors; RIC 3

Indexed keywords

BUNGAROTOXIN RECEPTOR; CYAN FLUORESCENT PROTEIN; NICOTINE; NICOTINIC RECEPTOR ALPHA4BETA2; PROTEIN; RESISTANT TO INHIBITORS OF ACETYLCHOLINESTERASE 3 PROTEIN; UNCLASSIFIED DRUG; NICOTINIC AGENT; NICOTINIC RECEPTOR; PROTEIN BINDING; PROTEIN SUBUNIT; RIC3 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; HEK293 CELL LINE; METABOLISM; PROTEIN SUBUNIT; PROTEIN TRANSPORT; UPREGULATION;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NICOTINE; NICOTINIC AGONISTS; PROTEIN BINDING; PROTEIN SUBUNITS; PROTEIN TRANSPORT; RECEPTORS, NICOTINIC; UP-REGULATION;

EID: 84876112243     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-14-47     Document Type: Article

References (56)

1. Nashmi R, Dickinson ME, McKinney S, Jareb M, Labarca C, Fraser SE, Lester HA. Assembly of α4β2 nicotinic acetylcholine receptors assessed with functional fluorescently labeled subunits: effects of localization, trafficking, and nicotine-induced upregulation in clonal mammalian cells and in cultured midbrain neurons. J Neurosci 2003, 23:11554-11567.
2. Vallejo YF, Buisson B, Bertrand D, Green WN. Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism. J Neurosci 2005, 25:5563-5572. 10.1523/JNEUROSCI.5240-04.2005, 2246082, 15944384.
3. Buisson B, Bertrand D. Chronic exposure to nicotine upregulates the human α4β2 nicotinic acetylcholine receptor function. J Neurosci 2001, 21:1819-1829.
4. Darsow T, Booker TK, Pina-Crespo JC, Heinemann SF. Exocytic trafficking is required for nicotine-induced up-regulation of α4β2 nicotinic acetylcholine receptors. J Biol Chem 2005, 280:18311-18320.
5. Moretti M, Mugnaini M, Tessari M, Zoli M, Gaimarri A, Manfredi I, Pistillo F, Clementi F, Gotti C. A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes. Mol Pharmacol 2010, 78:287-296. 10.1124/mol.110.064071, 20439469.
6. Nashmi R, Xiao C, Deshpande P, McKinney S, Grady SR, Whiteaker P, Huang Q, McClure-Begley T, Lindstrom JM, Labarca C, Collins AC, Marks MJ, Lester HA. Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci 2007, 27:8202-8218. 10.1523/JNEUROSCI.2199-07.2007, 17670967.
7. Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer I, Heinemann SF, Collins AC. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 1992, 12:2765-2784.
8. Perry DC, Davila-Garcia MI, Stockmeier CA, Kellar KJ. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther 1999, 289:1545-1552.
9. Kuryatov A, Luo J, Cooper J, Lindstrom J. Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors. Mol Pharmacol 2005, 68:1839-1851.
10. Sallette J, Pons S, Devillers-Thiery A, Soudant M, Prado de Carvalho L, Changeux JP, Corringer PJ. Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron 2005, 46:595-607. 10.1016/j.neuron.2005.03.029, 15944128.
11. Kawai H, Berg DK. Nicotinic acetylcholine receptors containing α7 subunits on rat cortical neurons do not undergo long-lasting inactivation even when up-regulated by chronic nicotine exposure. J Neurochem 2001, 78:1367-1378. 10.1046/j.1471-4159.2001.00526.x, 11579145.
12. Peng X, Gerzanich V, Anand R, Wang F, Lindstrom J. Chronic nicotine treatment up-regulates α3 and α7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol Pharmacol 1997, 51:776-784.
13. Nuutinen S, Ekokoski E, Lahdensuo E, Tuominen RK. Nicotine-induced upregulation of human neuronal nicotinic alpha7-receptors is potentiated by modulation of cAMP and PKC in SH-EP1-halpha7 cells. Eur J Pharmacol 2006, 544:21-30. 10.1016/j.ejphar.2006.06.038, 16846598.
14. Nuutinen S, Ahtee L, Tuominen RK. Time and brain region specific up-regulation of low affinity neuronal nicotinic receptors during chronic nicotine administration in mice. Eur J Pharmacol 2005, 515:83-89. 10.1016/j.ejphar.2005.04.003, 15894304.
15. Puchacz E, Buisson B, Bertrand D, Lukas RJ. Functional expression of nicotinic acetylcholine receptors containing rat alpha 7 subunits in human SH-SY5Y neuroblastoma cells. FEBS Lett 1994, 354:155-159. 10.1016/0014-5793(94)01108-7, 7957916.
16. Lee HK, Gwalani L, Mishra V, Anandjiwala P, Sala F, Sala S, Ballesta JJ, O'Malley D, Criado M, Loring RH. Investigating the role of protein folding and assembly in cell-type dependent expression of alpha7 nicotinic receptors using a green fluorescent protein chimera. Brain Res 2009, 1259:7-16.
17. Lansdell SJ, Gee VJ, Harkness PC, Doward AI, Baker ER, Gibb AJ, Millar NS. RIC-3 enhances functional expression of multiple nicotinic acetylcholine receptor subtypes in mammalian cells. Mol Pharmacol 2005, 68:1431-1438. 10.1124/mol.105.017459, 16120769.
18. Nguyen M, Alfonso A, Johnson CD, Rand JB. Caenorhabditis elegans mutants resistant to inhibitors of acetylcholinesterase. Genetics 1995, 140:527-535. 1206632, 7498734.
19. Millar NS. RIC-3: a nicotinic acetylcholine receptor chaperone. Br J Pharmacol 2008, 153(Suppl 1):S177-S183. 2268041, 18246096.
20. Wang Y, Yao Y, Tang X, Wang Z. Mouse RIC-3, an endoplasmic reticulum chaperone, promotes assembly of the alpha7 acetylcholine receptor through a cytoplasmic coiled-coil domain. J Neurosci 2009, 29:12625-12635. 10.1523/JNEUROSCI.1776-09.2009, 19812337.
21. Halevi S, McKay J, Palfreyman M, Yassin L, Eshel M, Jorgensen E, Treinin M. The C. elegans ric-3 gene is required for maturation of nicotinic acetylcholine receptors. EMBO J 2002, 21:1012-1020. 10.1093/emboj/21.5.1012, 125878, 11867529.
22. Alexander JK, Sagher D, Krivoshein AV, Criado M, Jefford G, Green WN. Ric-3 promotes alpha7 nicotinic receptor assembly and trafficking through the ER subcompartment of dendrites. J Neurosci 2010, 30:10112-10126. 10.1523/JNEUROSCI.6344-09.2010, 2945888, 20668195.
23. Castillo M, Mulet J, Gutiérrez LM, Ortiz JA, Castelán F, Gerber S, Sala S, Sala F, Criado M. Dual role of the RIC-3 protein in trafficking of serotonin and nicotinic acetylcholine receptors. J Biol Chem 2005, 280:27062-27068. 10.1074/jbc.M503746200, 15927954.
24. Halevi S, Yassin L, Eshel M, Sala F, Sala S, Criado M, Treinin M. Conservation within the RIC-3 gene family. Effectors of mammalian nicotinic acetylcholine receptor expression. J Biol Chem 2003, 278:34411-34417. 10.1074/jbc.M300170200, 12821669.
25. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, Miyawaki A. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol 2002, 20:87-90. 10.1038/nbt0102-87, 11753368.
26. Rizzo MA, Springer GH, Granada B, Piston DW. An improved cyan fluorescent protein variant useful for FRET. Nat Biotechnol 2004, 22:445-449. 10.1038/nbt945, 14990965.
27. Drenan RM, Nashmi R, Imoukhuede P, Just H, McKinney S, Lester HA. Subcellular trafficking, pentameric assembly, and subunit stoichiometry of neuronal nicotinic acetylcholine receptors containing fluorescently labeled α6 and β3 subunits. Mol Pharmacol 2008, 73:27-41.
28. Son CD, Moss FJ, Cohen BN, Lester HA. Nicotine normalizes intracellular subunit stoichiometry of nicotinic receptors carrying mutations linked to autosomal dominant nocturnal frontal lobe epilepsy. Mol Pharmacol 2009, 75:1137-1148. 10.1124/mol.108.054494, 2672806, 19237585.
29. Moss FJ, Imoukhuede PI, Scott K, Hu J, Jankowsky JL, Quick MW, Lester HA. GABA transporter function, oligomerization state, and anchoring: correlates with subcellularly resolved FRET. J Gen Physiol 2009, 134:489-521. 10.1085/jgp.200910314, 2806419, 19948998.
30. Srinivasan R, Pantoja R, Moss FJ, Mackey EDW, Son CD, Miwa J, Lester HA. Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning. J Gen Physiol 2011, 137:59-79. 3010053, 21187334.
31. Feige JN, Sage D, Wahli W, Desvergne B, Gelman L. PixFRET, an ImageJ plug-in for FRET calculation that can accommodate variations in spectral bleed-throughs. Microsc Res Tech 2005, 68:51-58. 10.1002/jemt.20215, 16208719.
32. Elangovan M, Wallrabe H, Chen Y, Day RN, Barroso M, Periasamy A. Characterization of one- and two-photon excitation fluorescence resonance energy transfer microscopy. Methods 2003, 29:58-73. 10.1016/S1046-2023(02)00283-9, 12543072.
33. Van Der Meer BW, Coker IIIG, Chen S-YS. 1994, New York: VCH, Resonance Energy Transfer: Theory and Data.
34. R Development Core Team R: A language and environment for statistical computing 2010, Vienna, Austria: , R foundation for statistical computing, URL http://www.R-project.org/, R Development Core Team.
35. Williams ME, Burton B, Urrutia A, Shcherbatko A, Chavez-Noriega LE, Cohen CJ, Aiyar J. Ric-3 promotes functional expression of the nicotinic acetylcholine receptor a7 subunit in mammalian cells. J Biol Chem 2005, 280:1257-1263.
36. Schwartz RD, Kellar KJ. Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 1983, 220:214-216. 10.1126/science.6828889, 6828889.
37. Marks MJ, Burch JB, Collins AC. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther 1983, 226:817-825.
38. Govind AP, Walsh H, Green WN. Nicotine-induced upregulation of native neuronal nicotinic receptors is caused by multiple mechanisms. J Neurosci 2012, 32:2227-2238. 10.1523/JNEUROSCI.5438-11.2012, 3286518, 22323734.
39. Zheng J, Zagotta WN. Stoichiometry and assembly of olfactory cyclic nucleotide-gated channels. Neuron 2004, 42:411-421. 10.1016/S0896-6273(04)00253-3, 15134638.
40. Cheng A, Bollan KA, Greenwood SM, Irving AJ, Connolly CN. Differential subcellular localization of RIC-3 isoforms and their role in determining 5-HT3 receptor composition. J Biol Chem 2007, 282:26158-26166. 10.1074/jbc.M703899200, 17609200.
41. Ben-Ami HC, Yassin L, Farah H, Michaeli A, Eshel M, Treinin M. RIC-3 affects properties and quantity of nicotinic acetylcholine receptors via a mechanism that does not require the coiled-coil domains. J Biol Chem 2005, 280:28053-28060. 10.1074/jbc.M504369200, 15932871.
42. St John PA. Cellular trafficking of nicotinic acetylcholine receptors. Acta Pharmacol Sin 2009, 30:656-662. 10.1038/aps.2009.76, 19498414.
43. Shehata M, Matsumura H, Okubo-Suzuki R, Ohkawa N, Inokuchi K. Neuronal stimulation induces autophagy in hippocampal neurons that is involved in AMPA receptor degradation after chemical long-term depression. J Neurosci 2012, 32:10413-10422. 10.1523/JNEUROSCI.4533-11.2012, 22836274.
44. Wecker L, Pollock VV, Pacheco MA, Pastoor T. Nicotine-induced up regulation of α4β2 neuronal nicotinic receptors is mediated by the protein kinase C-dependent phosphorylation of α4 subunits. Neuroscience 2010, 171:12-22. 10.1016/j.neuroscience.2010.09.005, 2957303, 20837109.
45. Exley R, Moroni M, Sasdelli F, Houlihan LM, Lukas RJ, Sher E, Zwart R, Bermudez I. Chaperone protein 14-3-3 and protein kinase a increase the relative abundance of low agonist sensitivity human alpha 4 beta 2 nicotinic acetylcholine receptors in xenopus oocytes. J Neurochem 2006, 98:876-885. 10.1111/j.1471-4159.2006.03915.x, 16787419.
46. Millar NS, Harkness PC. Assembly and trafficking of nicotinic acetylcholine receptors (review). Mol Membr Biol 2008, 25:279-292. 10.1080/09687680802035675, 18446614.
47. Jeanclos EM, Lin L, Treuil MW, Rao J, De Coster MA, Anand R. The chaperone protein 14-3-3eta interacts with the nicotinic acetylcholine receptor alpha 4 subunit. Evidence for a dynamic role in subunit stabilization. J Biol Chem 2001, 276:28281-28290. 10.1074/jbc.M011549200, 11352901.
48. Castelán F, Castillo M, Mulet J, Sala S, Sala F, Domínguez Del Toro E, Criado M. Molecular characterization and localization of the RIC-3 protein, an effector of nicotinic acetylcholine receptor expression. J Neurochem 2008, 105:617-627. 10.1111/j.1471-4159.2007.05169.x, 18179477.
49. Sparks JA, Pauly JR. Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl/6 mice. Psychopharmacol (Berl) 1999, 141:145-153.
50. Court JA, Lloyd S, Thomas N, Piggott MA, Marshall EF, Morris CM, Lamb H, Perry RH, Johnson M, Perry EK. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience 1998, 87:63-78. 10.1016/S0306-4522(98)00088-8, 9722142.
51. Harkness PC, Millar NS. Changes in conformation and subcellular distribution of α4β2 nicotinic acetylcholine receptors revealed by chronic nicotine treatment and expression of subunit chimeras. J Neurosci 2002, 22:10172-10181.
52. Peng X, Gerzanich V, Anand R, Whiting PJ, Lindstrom J. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol 1994, 46:523-530.
53. Marks MJ, McClure-Begley TD, Whiteaker P, Salminen O, Brown RWB, Cooper J, Collins AC, Lindstrom JM. Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain. J Pharmacol Exp Ther 2011, 337:187-200. 10.1124/jpet.110.178236, 3063733, 21228066.
54. Mao D, Perry DC, Yasuda RP, Wolfe BB, Kellar KJ. The alpha4beta2alpha5 nicotinic cholinergic receptor in rat brain is resistant to up-regulation by nicotine in vivo. J Neurochem 2008, 104:446-456.
55. Wang F, Nelson ME, Kuryatov A, Olale F, Cooper J, Keyser K, Lindstrom J. Chronic nicotine treatment up-regulates human alpha3 beta2 but not alpha3 beta4 acetylcholine receptors stably transfected in human embryonic kidney cells. J Biol Chem 1998, 273:28721-28732. 10.1074/jbc.273.44.28721, 9786868.
56. Teaktong T, Graham AJ, Johnson M, Court JA, Perry EK. Selective changes in nicotinic acetylcholine receptor subtypes related to tobacco smoking: an immunohistochemical study. Neuropathol Appl Neurobiol 2004, 30:243-254. 10.1046/j.0305-1846.2003.00528.x, 15175078.